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Background
Reduced ocular perfusion is related to several common eye
diseases, like age-related macular degeneration, diabetic
retinopathy or glaucoma. Moxaverine, a phosphodiesterase
inhibitor, has a vasodilating effect on peripheral vessels
and is therefore clinically used to increase blood flow. It
was recently shown that a dose of 150 mg moxaverine
administered intravenously increases retinal blood flow in
healthy subjects and in patients with ocular diseases. The
aim of this study was to investigate the effect of oral mox-
averine on ocular blood flow.
Methods
Sixteen healthy subjects were included in this randomized,
double-blinded, placebo-controlled, two-way crossover
study and two study days were scheduled. The subjects
were randomized to receive either 900 mg moxaverine
(p.o. in three equal doses at two-hour intervals) or placebo
o nt h ef i r s ts t u d yd a y .O nt h es e c o n ds t u d yd a yt h es u b -
jects were crossed over to the alternative treatment. Ocu-
lar haemodynamics were measured at baseline and
5 hours after the study drug administration. A Laser Dop-
pler Flowmeter was used to measure the choroidal and
optic nerve head blood flow. The blood velocities in the
retrobulbar vessels were assessed using the Color Doppler
Imaging.
Results
No difference was found in the haemodynamic para-
meters (choroidal, optic nerve head and retrobulbar
blood flow) between moxaverine and placebo group.
The p values for the choroidal and optic nerve head
blood flow were p = 0.52 and p = 0.54, respectively.
Similarly, the values assessed with the Color Doppler
Imaging also showed no significant difference. Addition-
ally, moxaverine had no effect on choroidal, optic nerve
head and retrobulbar blood flow.
Conclusions
Our results show that orally administered moxaverine,
in contrast to intravenous moxaverine, does not alter
the ocular blood flow. This may be related to the low
bioavailability of moxaverine after oral administration.
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